apl. Prof. Dr. Peter Goebell

Medizinische Fakultät Urologische Klinik

Treatment of patients with advanced urothelial carcinoma in routine care in Germany: initial data from the CARAT-UBC cohort (2022) Goebell P, Mueller L, Boegemann M, Rauh J, Nusch A, Andres-Pons A, Hamm N, et al. Conference contribution Drug Therapy Safety with new oral Antitumor Agents for the Therapy of Prostate and Renal Cell Carcinoma: Findings from the AMBORA Study (2022) Cuba L, Schlichtig K, Dürr P, Bellut L, Meidenbauer N, Kunath F, Goebell P, et al. Conference contribution New Oral Antitumor Drugs and Medication Safety in Uro-Oncology: Implications for Clinical Practice Based on a Subgroup Analysis of the AMBORA Trial (2022) Schlichtig K, Cuba L, Dürr P, Bellut L, Meidenbauer N, Kunath F, Goebell P, et al. Journal article LACK OF CONCORDANCE BETWEEN REAL-WORLD TREATMENT PATTERNS AND CLINICAL GUIDELINE RECOMMENDATIONS FOR METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) PATIENTS (2022) Goebell P, Shah R, Raina R, Rege S, Chen S, Partridge J, Waldeck R Conference contribution A Prospectivly Randomized Phase-II Trial of Axitinib versus Everolimus as Second-Line Therapy in Metastatic Renal Cell Carcinoma (BERAT Study) (2022) Grünwald V, Hilser T, Meiler J, Goebell P, Ivanyi P, Strauss A, Hartmann A, et al. Journal article Analysis of the Impact of Clinical Factors on Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction (2022) Oginski N, Apel H, Richterstetter M, Lieb V, Fiebig C, Goebell P, Wullich B, Sikic D Journal article IBCN Seminar Series 2021: Circulating tumor DNA in bladder cancer (2022) Christensen E, Wyatt AW, Galsky MD, Grivas P, Seiler R, Nawroth R, Goebell P, et al. Journal article, Review article Lifestyle aspects in a contemporary middle-European cohort of patients undergoing androgen deprivation therapy for advanced prostate cancer -data from the non-interventional LEAN study (2022) Schmitz-Dräger BJ, Bismarck E, Grammenos D, Ebert T, Starlinger R, Ottillinger B, Goebell P, et al. Journal article Biology of BCG response in non-muscle invasive bladder cancer - 2021 IBCN Updates Part III (2022) Reike MJ, Ingersoll MA, Müller DC, Zuiverloon TC, Strandgaard T, Kamat AM, Williams SB, et al. Journal article, Review article Discriminative capacity of guideline recommendations in the assessment of patients with asymptomatic microhematuria (2022) Kuckuck EC, Hennenlotter J, Todenhöfer T, Brünn LA, Rass GC, Stenzl A, Hakenberg OW, et al. Journal article